Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Related content
Volume 4, Number 10, October 2006

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Free Content Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
pp. 2103-2114(12)
Authors: SADLER, J. E.; BUDDE, U.; EIKENBOOM, J. C. J.; FAVALORO, E. J.; HILL, F. G. H.; HOLMBERG, L.; INGERSLEV, J.; LEE, C. A.; LILLICRAP, D.; MANNUCCI, P. M.; MAZURIER, C.; MEYER, D.; NICHOLS, W. L.; NISHINO, M.; PEAKE, I. R.; RODEGHIERO, F.; SCHNEPPENHEIM, R.; RUGGERI, Z. M.; SRIVASTAVA, A.; MONTGOMERY, R. R.; FEDERICI, A. B.

Favourites:Add to Favourites

Free Content The molecular basis of quantitative fibrinogen disorders
pp. 2115-2129(15)
Authors: ASSELTA, R.; DUGA, S.; TENCHINI, M. L.

Favourites:Add to Favourites

Free Content Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? Yes
pp. 2130-2132(3)
Authors: COHEN, A. T.; MAILLARDET, L. M. A.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Unveiling the inflammatory face of antiplatelet drugs
pp. 2137-2139(3)
Authors: DAVÌ, G.; SANTILLI, F.

Favourites:Add to Favourites

Free Content Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study
pp. 2140-2147(8)
Authors: WÆHRE, T.; DAMÅS, J. K.; PEDERSEN, T. M.; GULLESTAD, L.; YNDESTAD, A.; ANDREASSEN, A. K.; FRØLAND, S. S.; SEMB, A. G.; HANSTEEN, V.; GJERTSEN, E.; UELAND, T.; BROSSTAD, F.; SOLUM, N.O.; AUKRUST, P.

Favourites:Add to Favourites

Free Content New light on an old story: von Willebrand factor binding to collagen
pp. 2148-2150(3)
Authors: CHEN, J.; LÓPEZ, J. A.

Favourites:Add to Favourites

Free Content von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen
pp. 2151-2161(11)
Authors: BONNEFOY, A.; ROMIJN, R. A.; VANDERVOORT, P. A. H.; VAN ROMPAEY, I.; VERMYLEN, J.; HOYLAERTS, M. F.

Favourites:Add to Favourites

Free Content When it comes to von Willebrand disease, does 1 + 1 = 3?
pp. 2162-2163(2)
Author: MONTGOMERY, R. R.

Favourites:Add to Favourites

Free Content Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study
pp. 2164-2169(6)
Authors: CASTAMAN, G.; RODEGHIERO, F.; TOSETTO, A.; CAPPELLETTI, A.; BAUDO, F.; EIKENBOOM, J. C. J.; FEDERICI, A. B.; LETHAGEN, S.; LINARI, S.; LUSHER, J.; NISHINO, M.; PETRINI, P.; SRIVASTAVA, A.; UNGERSTEDT, J. S.

Favourites:Add to Favourites

Free Content Hemophilia and immunology at the crossroads
pp. 2170-2171(2)
Author: LOLLAR, P.

Favourites:Add to Favourites

Free Content Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain
pp. 2172-2179(8)
Authors: RAWLE, F. E.; PRATT, K. P.; LABELLE, A.; WEINER, H. L.; HOUGH, C.; LILLICRAP, D.

Favourites:Add to Favourites

Free Content Family secrets to be disclosed
pp. 2180-2181(2)
Authors: LINDQVIST, P. G.; CARLSON, J.

Favourites:Add to Favourites

Free Content Family history and inherited thrombophilia
pp. 2182-2187(6)
Authors: VAN SLUIS, G. L.; SÖHNE, M.; EL KHEIR, D. Y.; TANCK, M. W.; GERDES, V. E. A.; BÜLLER, H. R.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins
pp. 2191-2198(8)
Authors: CHEN, D.; WEBER, M.; SHIELS, P.G.; DONG, R.; WEBSTER, Z.; MCVEY, J. H.; KEMBALL-COOK, G.; TUDDENHAM, E. G. D.; LECHLER, R. I.; DORLING, A.

Favourites:Add to Favourites

Free Content Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial
pp. 2199-2203(5)
Authors: CUSHMAN, M.; GLYNN, R. J.; GOLDHABER, S. Z.; MOLL, S.; BAUER, K. A.; DEITCHER, S.; SHRIVASTAVA, S.; RIDKER, P. M.

Favourites:Add to Favourites

Free Content Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study
pp. 2204-2209(6)
Authors: BOEKHOLDT, S. M.; SANDHU, M. S.; WAREHAM, N. J.; LUBEN, R.; REITSMA, P. H.; KHAW, K-T

Favourites:Add to Favourites

Free Content A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests
pp. 2210-2214(5)
Authors: BUDD, R.; HARLEY, E.; QUARSHIE, A.; HENDERSON, V.; HARRIS, E. N.; PIERANGELI, S. S.

Favourites:Add to Favourites

Free Content Plasma contains protein S monomers and multimers with similar direct anticoagulant activity
pp. 2215-2222(8)
Authors: HEEB, M. J.; RADTKE, K.-P.; FERNÁNDEZ, J. A.; TONNU, L.

Favourites:Add to Favourites

Free Content Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII
pp. 2223-2229(7)
Authors: BARROW, R. T.; LOLLAR, P.

Favourites:Add to Favourites

Free Content Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo
pp. 2230-2237(8)
Authors: YANG, H.; REHEMAN, A.; CHEN, P.; ZHU, G.; HYNES, R. O.; FREEDMAN, J.; WAGNER, D. D.; NI, H.

Favourites:Add to Favourites

Free Content Thrombin induces GPIb-IX-mediated fibrin binding to αIIbβ3 in a reconstituted Chinese hamster ovary cell model
pp. 2238-2247(10)
Authors: PABÓN, D.; JAYO, A.; XIE, J.; LASTRES, P.; GONZÁLEZ-MANCHÓN, C.

Favourites:Add to Favourites

Free Content Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells
pp. 2248-2255(8)
Authors: CIRILLO, P.; PACILEO, M.; DE ROSA, S.; CALABRÒ, P.; GARGIULO, A.; ANGRI, V.; GRANATO-CORIGLIANO, F.; FIORENTINO, I.; PREVETE, N.; DE PALMA, R.; MAURO, C.; LEONARDI, A.; CHIARIELLO, M.

Favourites:Add to Favourites

Free Content Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells
pp. 2256-2261(6)
Authors: ROTH, G. A.; MOSER, B.; HUANG, S. J.; BRANDT, J. S.; HUANG, Y.; PAPAPANOU, P. N.; SCHMIDT, A. M.; LALLA, E.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Proposal to establish a European Association for Hemophilia and Allied Disorders
pp. 2270-2271(2)
Authors: LUDLAM, C. A.; MANNUCCI, P. M.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Body mass index and the risk of venous thrombosis among postmenopausal women
pp. 2273-2275(3)
Authors: OREN, E.; SMITH, N. L.; DOGGEN, C. J. M.; HECKBERT, S. R.; LEMAITRE, R. N.

Favourites:Add to Favourites

Free Content Identification of critical residues for regulation of integrin activation in the β6–α7 loop of the integrin β3 I-like domain
pp. 2278-2280(3)
Authors: HATO, T.; YAMANOUCHI, J.; YAKUSHIJIN, Y.; SAKAI, I.; YASUKAWA, M.

Favourites:Add to Favourites

Free Content Therapeutic range for unfractionated heparin therapy: age-related differences in response in children
pp. 2280-2283(4)
Authors: IGNJATOVIC, V.; SUMMERHAYES, R.; THAN, J.; GAN, A.; MONAGLE, P.

Favourites:Add to Favourites

Free Content Plasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects
pp. 2283-2284(2)
Authors: BURNIER, L.; BORGEL, D.; ANGELILLO-SCHERRER, A.; FONTANA, P.

Favourites:Add to Favourites

Free Content Functional analysis of two prothrombin 3′-untranslated region variants: the C20209T variant, mainly found among African-Americans, and the C20209A variant
pp. 2285-2287(3)
Authors: VAN DER PUTTEN, H. H. A. G. M.; SPAARGAREN-VAN RIEL, C. C.; BERTINA, R. M.; VOS, H. L.

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content ANNOUNCEMENTS
pp. 2291-2291(1)

Favourites:Add to Favourites

Free Content TALKING ABOUT…
pp. 2292-2294(3)
Authors: BRUTTOMESSO, G.; MIGLINO, N.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more